<--- Back to Details
First PageDocument Content
DNA repair / Fanconi anemia / FANCL / Mutation / Senescence / FANCE / FANCD2 / BRCA2 / FANCI / SLX4 / ERCC1 / FANCM
Date: 2016-03-02 05:04:57
DNA repair
Fanconi anemia
FANCL
Mutation
Senescence
FANCE
FANCD2
BRCA2
FANCI
SLX4
ERCC1
FANCM

List of up to 20 principal publications 1. Patel K.J, and Neuberger,M.S). ‘Antigen presentation by the B cell antigen receptor is driven by the α/β sheath and occurs independently of its cytoplasmic tyrosines

Add to Reading List

Source URL: www.biochem2.com

Download Document from Source Website

File Size: 61,16 KB

Share Document on Facebook

Similar Documents

crosoft PowerPoint - SPH11_A2_Curjuric [Schreibgesch4tzt]

crosoft PowerPoint - SPH11_A2_Curjuric [Schreibgesch4tzt]

DocID: 1qOG9 - View Document

List of up to 20 principal publications  1. Patel K.J, and Neuberger,M.S). ‘Antigen presentation by the B cell antigen receptor is driven by the α/β sheath and occurs independently of its cytoplasmic tyrosines

List of up to 20 principal publications 1. Patel K.J, and Neuberger,M.S). ‘Antigen presentation by the B cell antigen receptor is driven by the α/β sheath and occurs independently of its cytoplasmic tyrosines

DocID: 1pqXJ - View Document

sciFLEXARRAYER Application Note NoDrug screening and siRNA transfection using a “DropChip” cell array In order to perform information-rich high-throughput screening, a “DropChip” microarray has been devel

sciFLEXARRAYER Application Note NoDrug screening and siRNA transfection using a “DropChip” cell array In order to perform information-rich high-throughput screening, a “DropChip” microarray has been devel

DocID: 19kEb - View Document

Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients

Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients

DocID: 15Zya - View Document

Romano Danesi, MD, PhD University of Pisa +Pharmacogenomics is strategic companion in current clinical development of novel

Romano Danesi, MD, PhD University of Pisa +Pharmacogenomics is strategic companion in current clinical development of novel

DocID: 11Rt2 - View Document